lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2-Reference-Cited by-同舟云学术

lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2

Published:2023-07 Issue: Volume:69 Page:100975
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Wen Qing,Huang Maohua,Xie Jingwen,Liu Runyu,Miao Qun,Huang Jinjun,Zhang Junqiu,lyu Wenyu,Qi Ming,Wu Chunyi,Qi Qi,Zhang Zhijing,Deng Rong,Wang Chenran,Chen Zhe-Sheng,Zhang Dongmei,Ye Wencai,Chen Minfeng

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference52 articles.

1. Metabolic symbiosis enables adaptive resistance to anti-angiogenic therapy that is dependent on mTOR signaling;Allen;Cell Rep.,2016

2. Long noncoding RNA and cancer: a new paradigm;Bhan;Cancer Res.,2017

3. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models;Bridgeman;J. Pathol.,2017

4. LNCcation: lncRNA localization and function;Bridges;J. Cell Biol.,2021

5. Long noncoding RNA expression profiling reveals upregulation of uroplakin 1A and uroplakin 1A antisense RNA 1 under hypoxic conditions in lung cancer cells;Byun;Mol. Cells,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HAND2-AS1 plays a tumor-suppressive role in hepatoblastoma through the negative regulation of CDK1;Heliyon;2024-09

2. The Cancer Antioxidant Regulation System in Therapeutic Resistance;Antioxidants;2024-06-27

3. Vessel co-option: a unique vascular-immune niche in liver cancer;Frontiers in Oncology;2024-04-26

4. Propofol‐induced LINC01133 inhibits the progression of colorectal cancer via miR‐186‐5p/NR3C2 axis;Environmental Toxicology;2023-12-26

5. ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy;Nature Metabolism;2023-09-04